ShareValue scores for 300147.SHE: Valuation 43, Quality 30, Growth 39, Health 40.

300147.SHE
SZSE

Xiangxue Pharmaceutical

CN¥7.80(+2.50%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

4% to 16%
Valuation
43
Fair Value
Price vs Value
Quality
30
Weak
Business Strength
Growth
39
Weak
Revenue & Earnings
Health
40
Moderate
Financial Stability
Momentum
6
Bearish
Price Trend

Company Details

About

Xiangxue Pharmaceutical Co.,Ltd. engages in the research and development, production, and sales of modern Chinese medicine in China. The company provides ban lan gen granules, flu-over liquid, juhong cough-off liquid, and juhong cough-off decoction; chinese herbal, such as huazhou citri grandis, goji berry, chrysanthemum, and rose dried buds; beverages, including king sarsae, asia sarsae, diet sarsae, juice soda, soymilk, coconut juice, and fruit enzyme; and antiviral oral liquids under the Xiangxue brand name. It also provides medical devices, which includes disposable stereoscopic fixation system for brain; medical orthopedic and cosmetic adhesives; medical tumor serosa sealing adhesives; medical anastomotic adhesives; medical aural and encephalic adhesives; medical obturation adhesives; medical adhesives; and endoscopic trocar. The company was founded in 1986 and is based in Guangzhou, China. Address: No. 2 Jinfengyuan Road, Guangzhou, China, 510663

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026